CareRx (TSE:CRRX) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CareRx Corporation reported a mixed financial performance for Q2 2024 with a revenue of $92.0 million and an increased adjusted EBITDA of $7.5 million, despite facing a net loss of $1.4 million. The company remains committed to improving productivity and managing costs, while capitalizing on growth opportunities in the seniors living sector.
For further insights into TSE:CRRX stock, check out TipRanks’ Stock Analysis page.